News | July 14, 2010

NIH Grant Will Fund Study on Predicting Sudden Cardiac Arrest


July 14, 2010 – The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.

“Less than five percent of the people who have a sudden cardiac arrest survive, so we have to find a way to predict who is susceptible,” said Sumeet S. Chugh, M.D., the study’s principal investigator and an internationally renowned expert in sudden cardiac arrest. “If we can predict, we can prevent.”

Although “sudden cardiac arrest” and “heart attack” are often used interchangeably, the terms are not synonymous. Unlike heart attacks (myocardial infarction), which are typically caused by clogged coronary arteries reducing blood flow to the heart muscle, sudden cardiac arrest is the result of defective electrical activity of the heart. Patients may have little or no warning, and the disorder usually causes instantaneous death.

Chugh, an associate director of the Cedars-Sinai Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research, said the work is based on a key finding from patients’ electrocardiograms, also known as ECGs or EKGs. In a normal heart, an electrical impulse traveling through the ventricles of a beating heart takes less than 120 milliseconds to make the journey. Chugh said his preliminary research shows that the journey may be slightly longer in patients who later experience sudden cardiac arrest.

The new grant will enable Chugh and his team to dissect specific relationships between the delayed impulse measurement (called a prolonged QRS duration), other heart and non-heart related conditions, as well as specific abnormalities in the human genome, with the ultimate goal of enhancing the ability of cardiologists to identify the individual at highest risk of sudden cardiac arrest.

In addition to his leadership role at the Cedars-Sinai Heart Institute, Chugh heads the Oregon Sudden Unexpected Death Study, a comprehensive, 16-hospital, multi-year assessment of cardiac deaths in the Portland, Ore. metropolitan area, now going on for close to a decade. The data collected in that study provides Chugh and his team with unique, community-based information to mine for answers to what causes sudden cardiac arrest. Chugh’s Sudden Death Genomics Laboratory at the Heart institute is funded by two previous grants from the National Heart, Lung and Blood Institute that also enable ongoing work on solving mechanisms of sudden cardiac arrest.


Related Content

News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
News | ECG

July 17, 2025 — Royal Philips, a global leader in health technology, has launched the Philips ECG AI Marketplace, a ...

Home July 17, 2025
Home
News | ECG

July 10, 2025 — A study led by scientists at King's College London has revealed how the physical orientation of the ...

Home July 10, 2025
Home
News | ECG

May 8, 2025 – AccurKardia, an innovator in ECG-based diagnostics technology, recently announced that its AccurECG ...

Home May 19, 2025
Home
News | ECG

November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...

Home November 21, 2023
Home
News | ECG

October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...

Home October 13, 2023
Home
News | ECG

October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...

Home October 13, 2023
Home
News | ECG

September 26, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 26, 2023
Home
News | ECG

September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

Home September 06, 2023
Home
Subscribe Now